BioAffinity Total Liab vs Accounts Payable Analysis
| BIAFW Stock | USD 0.57 0.13 18.57% |
BioAffinity Technologies financial indicator trend analysis is way more than just evaluating BioAffinity Technologies prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BioAffinity Technologies is a good investment. Please check the relationship between BioAffinity Technologies Total Liab and its Accounts Payable accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in bioAffinity Technologies Warrant. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
Total Liab vs Accounts Payable
Total Liab vs Accounts Payable Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BioAffinity Technologies Total Liab account and Accounts Payable. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between BioAffinity Technologies' Total Liab and Accounts Payable is -0.02. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of bioAffinity Technologies Warrant, assuming nothing else is changed. The correlation between historical values of BioAffinity Technologies' Total Liab and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of bioAffinity Technologies Warrant are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Total Liab i.e., BioAffinity Technologies' Total Liab and Accounts Payable go up and down completely randomly.
Correlation Coefficient | -0.02 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.Accounts Payable
An accounting item on the balance sheet that represents BioAffinity Technologies obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of BioAffinity Technologies are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Most indicators from BioAffinity Technologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BioAffinity Technologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in bioAffinity Technologies Warrant. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. At this time, BioAffinity Technologies' Tax Provision is fairly stable compared to the past year. Selling General Administrative is likely to climb to about 7.1 M in 2024, whereas Issuance Of Capital Stock is likely to drop 0.00 in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 1.0M | 2.5M | 37.1K | 35.3K | Depreciation And Amortization | 4.8K | 10.2K | 249.6K | 262.1K |
BioAffinity Technologies fundamental ratios Correlations
Click cells to compare fundamentals
BioAffinity Technologies Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for BioAffinity Stock Analysis
When running BioAffinity Technologies' price analysis, check to measure BioAffinity Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAffinity Technologies is operating at the current time. Most of BioAffinity Technologies' value examination focuses on studying past and present price action to predict the probability of BioAffinity Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAffinity Technologies' price. Additionally, you may evaluate how the addition of BioAffinity Technologies to your portfolios can decrease your overall portfolio volatility.